Discover the PREZISTA Once-Daily PREZISTA® Once-Daily PREZISTA®
® EXPERIENCE (darunavir) isn’t just an HIV treatment. It’s an
HIV treatment experience as unique as you. That’s why you should ask your healthcare professional if the PREZISTA®
Experience is right for you. taken with ritonavir and in combination with other
HIV medications can help lower your viral load and keep your HIV under control over the long term.
In a clinical study* of almost 4 years (192 weeks), 7 out of 10 adults who had never taken HIV medications before maintained undetectable† viral loads with PREZISTA®
plus ritonavir and Truvada.®
Ask your healthcare professional about the PREZISTA® Experience. And be sure to visit
ExplorePREZISTA.com for tools and helpful information to fi nd out if the PREZISTA®
Experience might be right for you.
Please read the Important Safety Information and Patient Information on adjacent pages.
Go to
ExplorePREZISTA.com
*A randomized open label Phase 3 trial comparing PREZISTA®
/ritonavir 800/100 mg once daily (n=343) vs. Kaletra®/ritonavir 800/200 mg/day (n=346).
†Undetectable was defi ned as a viral load of less than 50 copies per mL. Registered trademarks are the property of their respective owners.
Janssen Therapeutics, Division of Janssen Products, LP
© Janssen Therapeutics, Division of Janssen Products, LP 2013 06/13 K28PRZ121037D
Once-Daily
^
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44